Beranda › Kolitis Ulseratif › South Carolina
Uji klinis Kolitis Ulseratif di South Carolina
12 studi untuk Kolitis Ulseratif mencari peserta di lokasi di South Carolina.
Kota di South Carolina
Teks studi resmi (Bahasa Inggris)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Patewood Medical Campus /ID# 272477, Greenville
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07071519A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0099, Charleston
Menerima pesertaFase 2/3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Associates - Patewood, Greenville
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Associates, P.A. of Greenville, Greenville
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Medical University of South Carolina, Charleston
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07415044An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Biocentric Health Research Partner, West Columbia
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Columbia Digestive Health Research (Objective Health), Columbia
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Medical University of South Carolina (MUSC), Charleston
Menerima pesertaStudi observasional
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.